Comparing Treatment Strategies in Ankylosing Spondylitis

This chapter explores a study on the efficacy of TNF versus IL-17 inhibitors in ankylosing spondylitis patients, analyzing over 15,000 cases. It highlights the implications of treatment switches on remission times and disease activity levels, prompting further discussion on optimal therapeutic strategies.